
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Carotenoids
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Recipient : RDC Clinical
Deal Size : Inapplicable
Deal Type : Inapplicable
CaroRiteâ„¢ for Skin Health and Signs of Ageing
Details : Carotenoids is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Aging.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 14, 2025
Lead Product(s) : Carotenoids
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Recipient : RDC Clinical
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Beetroot
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Loughborough University
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effects of Nitrate, Caffeine, and Cold Exposure on Cardiovascular Function.
Details : Beetroot is a drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 19, 2024
Lead Product(s) : Beetroot
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Loughborough University
Deal Size : Inapplicable
Deal Type : Inapplicable
